Purchase Order 75N94023P00754
Award Date 8/23/23
Potential Completion Date 9/29/23
Potential Value $50K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price delivery order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $97,054.04 contract does not have a set-aside designation. Based on Illumina's history of supporting genomic research and diagnostics across federal agencies, this award is likely for the provision of Illumina's sequencing systems, consumables, and...
- The U.S. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a Firm Fixed Price Delivery Order contract to Illumina, Inc. to acquire Illumina sequencing reagents and consumables. The contract has a ceiling value of $122,354.40 and runs through September 30, 2022. Illumina is a manufacturer of genetic and genomic analysis instruments and reagents, and has previously provided sequencing systems and related products to support research and diagnostics across various...
- This is a firm fixed price delivery order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis products. The contract has a ceiling value of $100,502.64 and a completion date of September 2, 2020. Illumina has provided various sequencing systems, reagents, consumables, and bioinformatics products to support genomic research and diagnostics for NIDDK...
- This is a firm fixed-price delivery order awarded by the National Institute on Aging, a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The $872,996.22 award is for the provision of Illumina reagent kits to support genomic analysis and sequencing work. This order falls under a larger Indefinite Delivery Contract that Illumina holds with the Department of the Navy's Bureau of Medicine and...
- This is a firm fixed price delivery order awarded by the National Institutes of Health (NIH) Clinical Center to Illumina, Inc. for the provision of Illumina reagent kits. The order, valued at $52,407.45, has a period of performance through September 30, 2024. There was no set-aside designation for this award. Based on Illumina's prior federal contract work, the company has provided a range of genomic sequencing instruments, reagents, and related services to support research and diagnostics...
- This firm fixed-price delivery order was awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $136,783.84 contract is for the provision of Illumina reagent kits to support genomic sequencing and analysis for research and diagnostic purposes. The award has a completion date of August 2, 2023. Illumina...
- This is a firm fixed price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH), a civilian federal agency. The order is for Illumina reagent kits, with a ceiling value of $10,498.14 and a period of performance through September 2, 2025. Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents, is the prime contractor. There is no set-aside designation for this...
- This federal contract was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The $12,446.03 firm fixed-price purchase order is for the supply of Illumina's NovaSeq 6000 S1 Reagent Kit V1.5, with an ultimate completion date of October 12, 2025. This contract does not utilize any set-aside designations. Illumina, a key technology provider for federal...
- This is a firm fixed price delivery order contract awarded by the Department of Health and Human Services National Institutes of Health National Institute on Aging to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis solutions, for the provision of laboratory supplies and reagent kits. The contract has a potential value of $157,326.62 and a completion date of June 13, 2023. The contract does not have a set-aside designation. Illumina has previously provided a range...
- This is a firm fixed price purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency under the Department of Health and Human Services, to Illumina, Inc. The contract, valued at $80,449.94, is for the provision of Illumina's sequencing and analytical instruments and reagents to support NIDDK's genomic research and diagnostics efforts. The contract has no set-aside designation. Illumina has previously been awarded prime...